1. strawberrynut11
2. konstas49
3. sahuebner
4. wolf3489
5. ps7geek
1.konstas49 03/07/2018
JMP Securities reiterates Outperform rating; PT raised to $20 from $11
2.strawberrynut11 06/25/2018
Zafgen Announces Positive Full Results in Phase 2 Proof-of-Concept Trial of ZGN-1061 in Patients with Difficult-to-Control Type 2 Diabetes
3.strawberrynut11 03/07/2018
Announces positive interim data from ongoing ZGN-1061 Phase 2 proof-of-concept trial in patients with Type 2…
NEW since the last time you visited this board.
Currently a TOP 10 POST for this board.
Currently a TOP 5 RESEARCHER for this board.
Specific post has replies to it.
A Researcher you are currently FOLLOWING
Other Researchers rate this post HIGH
Other Researchers rate this post LOW